Clinical Trial Update: Study of Lurbinectedin (PM01183) in Combination With Capecitabine in Patients With Metastatic Breast Cancer (MBC), Pancreatic Cancer (PC) or Metastatic Colorectal Cancer (CRC). [Phase 1]

View source ↗

Summary

This Phase 1 study evaluated the combination of lurbinectedin with capecitabine in patients with metastatic breast cancer, pancreatic cancer, or metastatic colo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Pancreatic Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Lurbinectedin (lurbinectedin)

Snippet

Sponsor: PharmaMar | Conditions: Metastatic Breast Cancer, Pancreatic Cancer | Phase 1 | Status: COMPLETED